SEC Form 4 · accession 0001628280-26-042863
Camp4 Therapeutics Corp · CAMP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Douglas E Williams
Director
Period of report
Jun 10, 2026
Accepted (ET)
Jun 12, 2026 · 4:16 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001736730
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $4.34 | Jun 10, 2026 | A | 28,000 | A | — | Jun 9, 2036 | Common Stock | 28,000 | 28,000 | D |
Explanation of responses
- F1The shares underlying the option vest in their entirety on the earlier of the first anniversary of the grant date or the date of the issuer's next annual meeting of stockholders, subject to continued service to the Company through the applicable vesting date.